Free Daily Podcast Summary
From Models to Medicine: Daily Summaries Delivered
by KAMI Think Tank
At KAMI Think Tank, we love cutting through the AI hype to showcase where the technology actually stands and how to use it meaningfully within the life sciences. Now, we're bringing that same clarity with our community to a brand new podcast: From Models to Medicine. Every week, we sit down with a real practitioner in the life sciences, whether they're working in the lab, leading innovation at a biotech, or building tools to better serve scientists. We discuss how they cut through the hype of AI and practically leverage the tool in their scientific workflows.
Latest Episodes
The most recent episodes — sign up to get AI-powered summaries of each one.
- 1 weeks ago43 min
Episode 28: The Algorithm Has a Women's Health Problem
We sit down with Geri Stengel, Forbes contributor, founder of Ventureneer, and co-chair of the Women's Health Technology Coalition, who has spent years reporting at the intersection of AI and women's health. Geri opens with a number that frames everything: from 1977 to 1993, the FDA recommended excluding women of childbearing age from clinical trials. That's nearly half of the core historical dataset that AI models are trained on.We get into the specialized companies building clinical-grade tools on narrow, targeted women's health data, why women are actually consenting to share their data at rates of up to 97%, and a systemic problem most people haven't heard of: search engines and social media platforms are routinely flagging standard medical terms like menstruation and menopause as adult content. That suppression drives up acquisition costs, distorts fundraising, and ultimately widens the health disparity gap. It's one of the more eye-opening conversations we've had on the show.Show notes:https://ventureneer.com/https://www.forbes.com/sites/geristengel/https://geristengel.substack.com/
- 2 weeks ago32 min
Episode 27: The Memory Code AI Is Starting to Crack
For this episode, we sit down with Kristeen Pareja-Navarro, co-CEO of Engram Bio, whose path from a farming family in the Philippines to peptide engineering for Alzheimer's disease at the Buck Institute is one of the more remarkable stories we've heard on the show. Kristeen walks us through her work trimming the KIBRA protein into a small functional peptide that rescues memory impairment in mice, and how tools like AlphaFold 3 and ESMFold have compressed years of structural biology work into days.But she's equally candid about where AI falls short. Intrinsically disordered proteins still break the models. AI summaries miss the nuances buried in figures and methods. And no amount of compute can answer the question the field is still wrestling with: how does memory persist when every cell in your body eventually turns over. A grounded, honest conversation about what AI is genuinely changing in early-stage drug development and what it isn't.Show Notes:https://www.biorxiv.org/content/10.64898/2026.06.03.729735v1.full.pdfhttps://www.nature.com/articles/s41586-025-09429-6
- 3 weeks ago24 min
Episode 26: Bigger Models Won't Save Biomanufacturing
We sit down with Shawn Manchester, CEO of TripleBar, whose path from yeast DNA repair to metabolic engineering at MIT to biomanufacturing AI gave him a front-row seat to one of biotech's most underappreciated problems. Everyone funds discovery. Nobody funds manufacturing. And yet a molecule that can't be made reliably and cheaply at scale never reaches a patient. Shawn makes the case that biomanufacturing is where the real bottleneck lives, and why it's finally getting the AI attention it deserves. It's a refreshingly grounded conversation about what biological AI actually requires to work.
- Sep 30, 202636 min
Episode 25: The 200-Page Protocol Problem AI Is Finally Solving
In this episode of From Models to Medicine, we sit down with Angie Schwab, CEO and founder of Trialynx, who has spent 20 years watching clinical trials run over budget, over timeline, and over complexity for one reason: nobody got rid of the copy-paste. Angie makes a sharp distinction that most people in the AI conversation are blurring. That automation and AI are not the same thing, and deploying generative AI on top of unstructured workflows without fixing the foundation first is how you get polished-looking documents that still require someone to fact-check every line.We get into how Trialynx compresses months of protocol documentation into 30 days, why a single source of truth changes everything downstream, and where Angie draws a hard line on what AI should never touch. The episode closes on a genuinely provocative idea: AI pseudo-clinical trials that run molecules through synthetic models of human biology before a single patient is enrolled.
- Sep 16, 202627 min
Episode 24: Beyond Correlation - Teaching AI the Rules of Biology
This week, we sit down with Jean-Baptiste Morlot of Deep Life, who makes the case that the drug discovery field has been asking the wrong thing of its AI models. Correlation-based machine learning can find patterns, but it can't tell you why a cell is sick or what it would take to make it healthy again. Jean-Baptiste walks us through how single-cell sequencing unlocked the data volume needed to train something far more ambitious: a causal world model of cellular biology that learns the underlying rules of disease rather than memorizing them.We get into how Deep Life's TwinCell platform works, why most virtual cell benchmarks are quietly inflated by popularity bias, and what it means to build an interpretable AI that a biologist can trust.
- Sep 2, 202630 min
Episode 23: When Biologists Start Thinking Like Engineers
This week, we sit down with Katie Lennon, CSO of Exthymic, who makes a case most bench scientists aren't ready to hear: biology isn't just a discovery discipline anymore. It's engineering. Katie walks us through what it actually looks like to build biology, hardware, and software concurrently, why that requires a shared language across disciplines, and what gets lost when teams hand off instead of collaborate.We also get into the unglamorous side of AI in the lab. More data documentation, peer-checking metadata before an experiment is marked complete, and knowing exactly where LLMs quietly get things wrong. Katie also shares a surprisingly effective strategy for getting scientists over their fear of AI tools. Companies mentioned in the show: https://exthymic.com/https://oni.bio/https://www.potato.ai/https://ollie.ai/-------------------Sign up for KAMI Think Tank's Maven course here! Classes start in less than 10 days!!
- Aug 26, 202645 min
Episode 22: The Model Was Never Built for Her
In this episode of From Models to Medicine, we sit down with Mark Amouzgar, co-founder and CEO of March Health. Mark opens with a striking stat: general-purpose AI models are only about 60% accurate in women's health. Sounding confident isn't the same as being clinically safe, and in this episode he breaks down exactly why generic AI was never built for this.We get into how March Health built a gender-aware digital twin, what it takes to wrap a model in real clinical logic, and why the average endometriosis patient sees eight different doctors before getting an accurate diagnosis. It's a candid conversation about a problem that doesn't get nearly enough attention.-------------------------Sign up for KAMI Think Tank's Maven course here!
- Aug 19, 202634 min
Episode 21: Glass Box Wins - What Pharma Actually Trusts in AI
In this episode of From Models to Medicine, we sit down with Lavanya Anandan, Head of External Innovation, West Coast at CSL, whose path from bench scientist to Merck Group platform builder to UCSF Innovation Venture startup advisor gives her a rare view of where AI in drug discovery is delivering versus where it's mostly promise. She makes a sharp case that the companies winning in AI-bio aren't necessarily the ones with the best models, and the reason why might surprise you.We get into what big pharma wants from an AI partner, why women's health data scarcity is quietly producing some of the most rigorous AI in biology, and what an unexpected finding in mRNA research tells us about where this whole field might be heading. Articles mentioned in show: https://endpoints.news/can-ai-do-scientific-research-billions-chase-hopes-of-superintelligence/Maven course: https://maven.com/kamithinktank/ai-literacy-for-life-sciences-healthcare
Get From Models to Medicine summaries in your inbox
Free AI-powered daily recaps. Key takeaways, quotes, and mentions — in a 5-minute read.
Get Free Summaries →Free forever for up to 3 podcasts. No credit card required.
You Might Also Like
Listeners also like.
How I AI
A practical guide to using AI tools in work and life, featuring guests who share specific, actionable techniques and workflows.
The AI in Business Podcast
Interviews with AI executives reveal practical applications and strategic insights for business leaders adopting AI.
This Week in AI
Four AI experts analyze the latest news and trends in artificial intelligence each week.
The AI Podcast
Explores artificial intelligence advancements, trends, and ethics for enthusiasts and professionals.
AI For Humans: Weekly AI News, Tools & Trends
A weekly breakdown of major AI news, tools, and breakthroughs for both newcomers and seasoned enthusiasts.
AI Breakdown
Explores the latest advancements, ethical issues, and real-world impacts of artificial intelligence across industries.
Everyday AI Podcast – An AI and ChatGPT Podcast
Covers practical uses of AI tools like ChatGPT and Midjourney to help people work more efficiently and advance their careers.
Machine Learning Street Talk (MLST)
Discussions with leading AI researchers and thinkers exploring machine learning, cognitive science, and philosophy of mind without hype.
Global News Podcast
Global News Podcast AI
Building AI Boston
Discusses artificial intelligence through real-world applications and ethical considerations in Boston’s tech community.
A Beginner's Guide to AI
Explores artificial intelligence through interviews and clear explanations for beginners and the curious.
Latent Space: The AI Engineer Podcast
Conversations with AI engineers, researchers, and founders on foundation models, AI agents, infrastructure, and scientific discovery.
About From Models to Medicine
At KAMI Think Tank, we love cutting through the AI hype to showcase where the technology actually stands and how to use it meaningfully within the life sciences. Now, we're bringing that same clarity with our community to a brand new podcast: From Models to Medicine. Every week, we sit down with a real practitioner in the life sciences, whether they're working in the lab, leading innovation at a biotech, or building tools to better serve scientists. We discuss how they cut through the hype of AI and practically leverage the tool in their scientific workflows.
Customized Recaps
AI-powered recaps with compact key takeaways, quotes, and insights.
Straight to Your Inbox
Get key takeaways from From Models to Medicine in a 5-minute read.
Save Hours Every Week
Stay current on your favorite podcasts without falling behind.
Frequently Asked Questions
What is Podzilla's From Models to Medicine daily summary?
It's a free AI-powered email that summarizes new episodes of From Models to Medicine as soon as they're published. You get the key takeaways, notable quotes, and links & mentions — all in a quick read.
How does the From Models to Medicine podcast summary work?
When a new episode drops, our AI transcribes and analyzes it, then generates a personalized summary tailored to your interests and profession. It's delivered to your inbox every morning.
Is this an official From Models to Medicine product?
No. Podzilla is an independent service that summarizes publicly available podcast content. We're not affiliated with or endorsed by KAMI Think Tank.
Can I get summaries of other podcasts too?
Absolutely! The free plan covers up to 3 podcasts, any in the catalog. Basic raises that to 15, Pro to 40 and Max to 100. Browse our full catalog at /podcasts.
How often does From Models to Medicine release new episodes?
From Models to Medicine publishes weekly. Our AI generates a summary within hours of each new episode.
What topics does From Models to Medicine cover?
From Models to Medicine covers topics including Science, Life Sciences. Our AI identifies the specific themes in each episode and highlights what matters most to you.
Start getting From Models to Medicine summaries tomorrow morning.
Free forever for up to 3 podcasts. No credit card required.
Free forever for up to 3 podcasts. No credit card required.